By: Midi Health
Transforming healthcare for women in midlife by providing expert care for women in perimenopause and menopause
57 million women in the U.S. are experiencing the universal female experience of hormone transition. For most, perimenopause and menopause come with symptoms that significantly harm quality of life. Nearly two thirds of women seek medical care for symptoms, but encounter a severe shortage of clinicians trained in midlife female health. Women are underdiagnosed, undertreated, and underserved in midlife healthcare, and require a solution that focuses on their unique needs. Midi Health provides that solution. Midi Health is the premier virtual health solution for women navigating midlife hormone transition. We provide care designed by experts, scaled by technology, delivered by trained and compassionate clinicians with services covered by insurance. We offer convenient access to care through telehealth visits, 24/7 messaging, hormonal, non-hormonal, and naturopathic solutions. Midi protocols are designed by the preeminent doctors in the field of menopause.
Telehealth-first platform: Patients can book virtual visits in minutes, with clinicians trained in midlife hormonal care.
Insurance coverage orientation: Their services—including clinician visits and prescription medications—are designed to be covered under many PPO/private insurance plans.
Comprehensive care plans: Tailored treatment regimens combine hormonal and non-hormonal therapies, supplements, lifestyle coaching, and ongoing monitoring.
Platform + clinical protocols: Midi establishes standardized clinical protocols (developed with menopause experts) that allow nurse practitioners and other providers to deliver consistent, scalable care.
Our superpower is our clinicians. They are experienced women’s health clinicians that are employees of Midi and trained by Midi to deliver our proprietary clinical protocols. Our clinical protocols are developed by a cadre of world renowned experts, integrating a multidisciplinary approach to our care. This allows us to scale quickly as we create our own network of best in class clinicians.
Midi Health partners with employers to provide benefit access to trained specialists that treat menopause and midlife symptoms and to address hormone depletion that impacts downstream health related to brain, bone, and cardiovascular health.
Midi Health is also integrating with notable health systems throughout the country. We augment the health system and physician capacity and help health systems create loyalty among post reproductive women to promote retention and to drive differentiation for hospitals supporting the needs of women in midlife.
By providing women the right care at the right time, delivered by our clinicians through protocolized care, Midi is able to impact spend. To determine cost savings, we are extrapolating from Dr. Phillip Sarrel's work at Yale. He completed an 11-year study of 500,000 claims and determined that women with vasomotor symptoms who are untreated cost $1300 more per capita in direct medical costs and $800 in lost productivity per capita. This was attributable to decreased ER and outpatient visits for women seeking solutions to midlife symptoms.
Sarrel, Philip, David Portman, Patrick Lefebvre, Marie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Fortier, Jonathan Gravel, Mei Sheng Duh, and Peter M. Aupperle. “Incremental Direct and Indirect Costs of Untreated Vasomotor Symptoms.” Menopause 22, no. 3 (March 2015): 260–266.